Berkay Demirors
Advertisement
Articles by Berkay Demirors
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
Adjuvant Therapy Confers Postoperative ctDNA Clearance, DFS Benefit in CRC
5
